Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Debulking Surgery for High Tumor Burden Ovarian Cancer

NCT02249013 is registered in ClinicalTrials.gov with Professor Fernando Figueira Integral Medicine Institute as lead sponsor.

NCT NCT02249013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02249013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Debulking Surgery for High Tumor Burden Ovarian Cancer
Lead sponsor
Professor Fernando Figueira Integral Medicine Institute
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2015
Completion date
February 23, 2021
Enrollment
15 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer